Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL308872 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27910602 | 0.96 | — | — | |
| SCHEMBL30570 | 0.95 | — | — | |
| SCHEMBL4805121 | 0.91 | — | — | |
| Methane SCHEMBL9114544 | 0.91 | — | — | |
| Fluoride SCHEMBL27659500 | 0.91 | — | — | |
| Water SCHEMBL20546842 | 0.91 | — | — | |
| Ethylene SCHEMBL28151594 | 0.87 | — | — | |
| Ethylene Glycol SCHEMBL28150623 | 0.84 | TSHR (0.44) | — | |
| SCHEMBL5772267 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050019742-A1 | Methods for assessment of platelet aggregation | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-01-27 | — | — | US | claimed |
| WO-2004036226-A1 | METHODS FOR ASSESSMENT OF PLATELET AGGREGATION | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-04-29 | — | — | WO | claimed |
| US-12121526-B2 | Targeting NCCA-ATP channel for organ protection following ischemic episode | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2024-10-22 | — | — | US | disclosed |
| US-20220193096-A1 | INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2022-06-23 | — | — | US | disclosed |
| WO-2021263115-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER, OVERCOMING PD-1/PD-L1 BLOCKADE RESISTANCE, AND DETERMINING RESISTANCE TO CHECKPOINT INHIBITOR TREATMENT | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2021-12-30 | — | — | WO | disclosed |
| EP-3710033-A1 | NUCLEAR-TARGETED DNA REPAIR ENZYMES AND METHODS OF USE | Oregon Health & Science University (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20200283745-A1 | NUCLEAR-TARGETED DNA REPAIR ENZYMES AND METHODS OF USE | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2020-09-10 | — | — | US | disclosed |
| US-20160195544-A1 | METHOD OF DIAGNOSING SEPSIS OR SEPSIS RISK | UNIVERSITY OF ROCHESTER (US) | 2016-07-07 | — | — | US | disclosed |
| US-9376684-B2 | Anticoagulant fusion protein anchored to cell membrane | IMPERIAL INNOVATIONS LIMITED (GB) | 2016-06-28 | — | — | US | disclosed |
| EP-3030576-A1 | METHOD OF DIAGNOSING SEPSIS OR SEPSIS RISK | University Of Rochester (US) | 2016-06-15 | — | — | EP | disclosed |
| CN-105555800-A | Method for diagnosing sepsis or sepsis risk | UNIV ROCHESTER | 2016-05-04 | — | — | CN | disclosed |
| US-20050118160-A1 | Inhibits delayed vascular rejection; makes organs less vulnerable to rejection after transplantation | IMPERIAL COLLEGE INNOVATIONS LIMITED | 2005-06-02 | — | — | US | disclosed |
| CN-1192109-C | Anticoagulant fusion protein anchored to cell membrane | IMP COLLEGE INNOVATION CO LTD (GB) | 2005-03-09 | — | — | CN | disclosed |
| US-20050019742-A1 | Methods for assessment of platelet aggregation | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-01-27 | — | — | US | disclosed |
| WO-2004062570-A2 | APPARATUS AND METHOD TO MEASURE PLATELET CONTRACTILITY | SALDIVAR ENRIQUE (US) | 2004-07-29 | — | — | WO | disclosed |
| WO-2004036226-A1 | METHODS FOR ASSESSMENT OF PLATELET AGGREGATION | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-04-29 | — | — | WO | disclosed |
| US-6423316-B1 | PROTEINS FOR CELL MEMBRANES WITH TARGET SEQUENCES OF POLYPEPTIDES | IMPERIAL COLLEGE INNOVATIVE LIMITED (GB) | 2002-07-23 | — | — | US | disclosed |
| CN-1265148-A | Cell membrane anchored anticoagulant fusion proteins | RPMS TECHNOLOGY LTD (GB) | 2000-08-30 | — | — | CN | disclosed |
| EP-1000161-A1 | ANTICOAGULANT FUSION PROTEIN ANCHORED TO CELL MEMBRANE | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2000-05-17 | — | — | EP | disclosed |
| WO-1998042850-A1 | ANTICOAGULANT FUSION PROTEIN ANCHORED TO CELL MEMBRANE | RPMS TECHNOLOGY LIMITED (GB) | 1998-10-01 | — | — | WO | disclosed |